Skip to main content

news

Shardul Amarchand Mangaldas & Co (SAM) has advised private equity major Advent International on the purchase of a 50.1 percent stake in India’s Suven Pharmaceuticals, with Cyril Amarchand Mangaldas (CAM) advising the sellers, the Jasti family.

According to Reuters, Advent is expected to make an additional open offer for up to 26 percent of the voting share capital held by public shareholders. Advent intends to explore merging Suven with its wholly owned Cohance Lifesciences to build a company that specializes in active pharmaceutical ingredients as well as contract development and manufacturing businesses, Reuters added.

 

The CAM team was led by partner Shishir Vayttaden, with support from partners Namrata Kolar, Biplab Lenin, and Avaantika Kakkar.

TO CONTACT EDITORIAL TEAM, PLEASE EMAIL ALBEDITOR@THOMSONREUTERS.COM

Related Articles

Deals

Trilegal, Khaitan guide RMZ-Colt $1.7 bln India data centre JV

by Nimitt Dixit |

Trilegal advised Indian alternative asset owner RMZ Group on its $1.7 billion joint venture with Colt Data Centre Services, which was advised by Khaitan & Co, to invest in the Indian data centre market, as well as the proposed acquisition of stakes in two data centre projects.

Deals

HSF, CC lead on SF Holdings’ $750 mln Hong Kong IPO

by Hu Yangxiaoxiao 胡阳潇潇 |

Herbert Smith Freehills, CM Law Firm, and Grandall Law Firm have advised Chinese logistics provider SF Holdings on its $750 million initial public offering in Hong Kong, with Clifford Chance and King & Wood Mallesons advising the joint sponsors.

Deals

Bakers, HSF act on PE acquisition of Japan’s jinjer

by Nimitt Dixit |

Baker & McKenzie (Gaikokuho Joint Enterprise) has advised private equity firms J-STAR Co and Potentia Capital on their joint acquisition of jinjer, one of Japan’s leading HR SaaS players. While financial terms were not recorded, news reports value the deal at $500 million.